Analyst Report: IT
1. EXECUTIVE SUMMARY
Gartner (IT) rose 5.74% to $219.64 on Tuesday October 20, 2026, on volume of 1,911,000 shares, 1.77x its 50-session average. According to StockStory via Yahoo, the shares jumped in the afternoon after Truist and Wells Fargo raised price targets following meetings at the company's IT Symposium. Truist lifted its target from $205 to $235 on a Buy rating, and Wells Fargo moved from $150 to $175 on an Underweight rating (Investing.com). Peers rose by smaller amounts (ACN +0.92%, IBM +2.34%, CTSH +2.08%) and the S&P 500 gained 0.28%, so the move was largely stock-specific. The shares have gained 22.88% over 20 sessions and 48.96% over 60 sessions, yet remain 7.34% lower year to date. The next test is the Q3 report on November 3.
2. THE CATALYST
StockStory via Yahoo (2026-10-20) reported that the shares jumped in the afternoon session after Truist Securities and Wells Fargo both raised targets following meetings around the IT Symposium.
| Broker | Rating | Target change | Source |
|---|---|---|---|
| Truist | Buy (maintained) | $205 to $235 | Investing.com, 2026-10-20 |
| Wells Fargo | Underweight (maintained) | $150 to $175 | Investing.com, 2026-10-20 |
| UBS | Neutral | $196 to $208 | Investing.com, 2026-10-20 |
Investing.com reported that Truist's analyst met management at the Symposium and that conference attendance was up double digits year on year. Truist read this as a positive for the Conferences segment in 2027 more than for Q3 Insights contract value. It described management as measured, citing choppy macro conditions and changes to the BTI product, while expressing long-term confidence in contract-value acceleration. Wells Fargo's note followed Symposium discussions on the BTI product transformation, where it sees AI-driven uncertainty raising client engagement.
UBS raised its target to $208 according to the body of the Investing.com article, although the headline says "reiterates". It expects modest contract-value upside, with Street estimates at 2.5% against its own 2.3%.
Gartner's neocloud forecast and CIO survey research appeared on October 19 and 20 (24/7 Wall St.). The stock closed up 1.15% on October 19, the day the research first broke, so that research does not account for the October 20 move. Headline-only items on RBC and BMO could not be confirmed and are left out.
3. COMPANY PROFILE
Gartner provides business and technology insights through three segments: Insights (subscriptions to research, data, benchmarks and expert access), Conferences and Consulting. It sits in the Information Technology Services industry, and the peer group used here is IT consulting and other services, including Accenture, IBM and Cognizant.
Per Investing.com (date unconfirmed, likely early August), second-quarter adjusted EPS was $4.37 against roughly $3.76 expected, and revenue was $1.67bn against $1.65bn expected. The company repurchased $547 million of stock in the quarter. Yahoo Finance (date unconfirmed) reported full-year adjusted EPS guidance raised to $14 from $13.25 and free cash flow guidance to $1.19bn from $1.16bn. Market capitalisation is $13.87bn, with a forward P/E of 13.4 and a trailing P/E of 19.9.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The evidence is thin for a 5.74% gain. Target raises and a positive Symposium read on attendance are real data points, but neither changes reported results. Truist's own comments tie the benefit to 2027 Conferences revenue and describe a measured management tone on near-term conditions. Wells Fargo remains Underweight, and its $175 target sits below the $219.64 close, as does UBS's $208. Truist's $235 target is the only one among the confirmed actions that sits above the current price. In my inference, the move reflects a shift in sentiment from a depressed base more than new numbers.
Comparable episodes.
| Date | Trigger | Reaction |
|---|---|---|
| 2026-10-08 | Morgan Stanley target raise (MarketBeat) | +5.19% on the day |
| 2026-10-15 | Sector-wide IT services rally, no company news (AlphaStreet) | +5.89% |
| Early August (date unconfirmed) | Q2 beat and raised guidance | About 7% rise (Investing.com) |
| 2026-02-03 | Weak Q4 results and 2026 guidance (TIKR) | Fall of more than 21% |
The stock has now posted three sessions of roughly 5% or more in two weeks. It is highly reactive to analyst commentary at present, which is consistent with a stock that fell sharply in February and has since rebuilt from a 52-week low of $124.25 on 2026-06-22.
Peers. ACN, IBM and CTSH rose between 0.92% and 2.34% over the same period. Gartner's gain was larger than all of them, which points to a company-specific driver on October 20.
Bull case. Double-digit conference attendance growth, a raised full-year guide, active buybacks and a forward P/E of 13.4 leave room for re-rating. Truist argues that expectations are low enough that an in-line contract-value print and a reiterated exit-rate target would support the shares.
Bear case. Management flagged choppy macro conditions and product changes. Most targets sit below the share price, and Morgan Stanley (Equal Weight, $182 target as of October 8) and UBS (Neutral) are not advocates. The February drop shows how heavily the shares can fall on a guidance miss.
5. TECHNICAL SNAPSHOT
The $219.64 close is the highest in the ten-session table and sits above the 50-day average of $189.67 and the 200-day average of $169.94, so the trend is firmly up. The shares are about 16% below the 52-week high of $261.10 set on 2025-10-21 and well above the June low. Volume of 1,911,000 was the heaviest in the table and 1.77x the 50-session average, which gives the advance more weight than the 5.89% rise on October 15 on 1,174,300 shares. Because the latest close is the highest in the table, no resistance level is named from the recent closes. The nearest support is $207.72, the October 19 close.
6. RISK FACTORS
- Fading sentiment. Much of the move rests on target changes and a conference read, so the gains can unwind when attention shifts.
- Insights contract value. Truist's positive view centres on 2027 Conferences, and the Q3 contract-value print is the nearer test. UBS expects 2.3% against Street estimates of 2.5%.
- Macro and product transition. Management cited choppy macro conditions and BTI product changes.
- Sector swings. The October 15 rally had no company catalyst, so sector sentiment can move the shares in either direction.
- Unconfirmed items. The timing of the Truist note is unclear (Investing.com says "Monday"), and the RBC and BMO targets are unverified.
Dated catalyst: Q3 2026 results on 2026-11-03, before the open, with an EPS estimate of $2.84 and a revenue estimate of $1.49bn.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). After a gain of 11.52% in five sessions, the shares sit well above most published targets. The October 19 close of $207.72 is the nearest support. Further direction depends on whether volume stays elevated and on positioning ahead of the November 3 report.
Medium term (1-3 months). The Q3 result and the exit-rate contract-value commentary will decide whether the re-rating holds. An in-line print with a reiterated target would support the shares according to Truist, while a miss on contract value would put the recent gains at risk, given the February precedent.
Long-term thesis. The brief shows no change in the long-term thesis. Raised guidance, buybacks and growing conference attendance support it, and the AI-driven product transition remains the main open question. This is analysis, not personal financial advice.